Alterity Therapeutics (ATHE) Change in Accured Expenses (2009 - 2020)

Alterity Therapeutics' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $10868.2 for Q2 2020.

• In Q2 2020, Change in Accured Expenses fell 67.24% year-over-year to $10868.2; the TTM figure through Jun 2020 stood at $23360.8 (down 84.05% YoY), while the FY2024 annual figure was -$7.9 billion, changed N/A from the prior year.
• Change in Accured Expenses was $10868.2 for Q2 2020 at Alterity Therapeutics, up from -$48058.2 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $86708.3 in Q4 2017 to a low of -$48058.2 in Q4 2019.
• Historically, Change in Accured Expenses has averaged $20907.9 across 5 years, with a median of $19121.7 in 2018.
• Biggest YoY gain for Change in Accured Expenses was 4125.31% in 2019; the steepest drop was 275.55% in 2019.
• A 5-year view of Change in Accured Expenses shows it stood at -$9017.2 in 2016, then jumped by 1061.59% to $86708.3 in 2017, then tumbled by 68.43% to $27375.1 in 2018, then slumped by 275.55% to -$48058.2 in 2019, then soared by 122.61% to $10868.2 in 2020.
• The last three Change in Accured Expenses figures came in at $10868.2 (Q2 2020), -$48058.2 (Q4 2019), and $33175.8 (Q2 2019), per Business Quant data.